Delivery Order SPE2DR25D3301-SPE2DR26F21SN
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $43,698.88 to Amerisourcebergen Drug Corp (a subsidiary of Cencora, Inc.) on January 20, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30. This competitively awarded, firm fixed-price delivery order is non-set-aside and carries an ultimate completion date of January 21, 2026, with performance occurring at the contractor's Conshohocken, Pennsylvania location. The award represents a task order executed under a broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,129.25 to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside contract with performance scheduled for completion by January 23, 2026, with fulfillment occurring at the vendor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a $12,507.84 delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of January 5, 2026, and represents a child order under a larger contract vehicle. The award carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, valued at $4,584.29. This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, issued under a competitive procurement with no set-aside designation. The order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,042.32 to AmerisourceBergen Drug Corp for supply of Vemlidy 25 mg tablets (30 count) on January 9, 2026, with an ultimate completion date of January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., operates as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units at a firm fixed price ceiling value of $7,543.09. This non-set-aside delivery order represents a routine pharmaceutical procurement supporting federal healthcare operations. The contract is scheduled for ultimate completion on May 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $3,637.91 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count packaging) on November 3, 2025, with completion scheduled for November 4, 2025. This firm fixed-price delivery order represents a direct pharmaceutical procurement from the prime contractor's corporate office located in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting open competition...
- The Defense Logistics Agency awarded a $9,560.12 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) under a firm fixed-price contract. The award was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and represents a non-set-aside, competitively awarded procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery at its corporate office location, fulfilling the federal...
- The Defense Logistics Agency awarded a delivery order valued at $4,932.38 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 9, 2026, with completion scheduled for January 12, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $4,822.46 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on January 2, 2026, with an ultimate completion date of January 5, 2026. This competitively awarded, firm fixed-price contract represents a non-set-aside delivery order for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for the...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F21SNDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, valued at approximately $85,000, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. The contract was executed on February 2, 2026, with an ultimate completion date of February 3, 2026, utilizing firm fixed pricing with no set-aside designation. The order will be fulfilled from the awardee's Conshohocken, Pennsylvania location, supporting federal medical procurement requirements for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999 through December 31, 2031. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. Cencora, Inc. competes on a full and open basis for federal contracts and serves critical federal healthcare customers including the Defense Health Agency and the U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $85.0k | 2/1/26 |